Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01346696
Other study ID # CHN-0005
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2011
Est. completion date March 2016

Study information

Verified date October 2019
Source Dentsply Sirona Implants
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 6 mm implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible and maxilla up to 3 years after loading. The hypothesis is that one stage surgery using 6 mm OsseoSpeed™ TX implant in the posterior region is safe and predictable.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender All
Age group 20 Years to 75 Years
Eligibility Inclusion criteria:

1. Provision of informed consent

2. Female and male aged 20-75 years at enrolment

3. In need for 2-3 implants in either side of the posterior mandible or maxilla (premolar and molar region)

4. History of edentulism in the study area of at least four months

5. Neighboring tooth/teeth to the planned bridge/crowns must have natural root(s)

6. Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge/crowns

7. Deemed by the investigator to be suitable for implants of 6 mm length and to have a bone height of at least 6 mm and a bone width of minimum 6 mm

8. Deemed by the investigator as likely to present an initially stable implant situation

Exclusion criteria:

1. Unlikely to be able to comply with study procedures, as judged by the investigator

2. Earlier graft procedures in the study area

3. Uncontrolled pathologic processes in the oral cavity

4. Known or suspected current malignancy

5. History of radiation therapy in the head and neck region

6. History of chemotherapy within 5 years prior to surgery

7. Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration

8. Uncontrolled diabetes mellitus

9. Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration

10. Smoking more than 10 cigarettes/day

11. Present alcohol and/or drug abuse

12. Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)

13. Previous enrolment in the present study

14. Simultaneous participation in another clinical study, or participation in a clinical study during the last 6 months

15. Subjects that are unable to give informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
OsseoSpeed™ TX implant (Ø 4.0 mm, length 6 mm)


Locations

Country Name City State
China Department of Implantology, School of Stomatology, Peking University Beijing
China Department of Periodontology, School of Stomatology, Peking University Beijing
China Second Dental and Periodontal Center, School of Stomatology, Peking University Beijing

Sponsors (1)

Lead Sponsor Collaborator
Dentsply Sirona Implants

Country where clinical trial is conducted

China, 

References & Publications (2)

Han J, Tang Z, Zhang X, Meng H. A prospective, multi-center study assessing early loading with short implants in posterior regions. A 3-year post-loading follow-up study. Clin Implant Dent Relat Res. 2018 Feb;20(1):34-42. doi: 10.1111/cid.12568. Epub 2017 — View Citation

Han J, Zhang X, Tang Z, Zhang L, Shi D, Meng H. A prospective, multicenter study assessing the DENTSPLY Implants, OsseoSpeed(™) TX, length 6 mm in the posterior maxilla and mandible: a 1-year follow-up study. Clin Oral Implants Res. 2016 Apr;27(4):452-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Marginal Bone Level Alteration Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant, and expressed in millimeters. Marginal Bone Level change calculated from values obtained at delivery of permanent restoration i.e. loading of implants (baseline) compared to the values obtained at the follow-up visit 12 months after loading.
Positive value = bone gain, Negative values = bone loss.
Evaluated from implant installation to 12 months after implant loading
Secondary Marginal Bone Level Alteration After 36 Months Marginal Bone Level determined from radiographs and expressed as the difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant, and expressed in millimeters. Marginal Bone Level change calculated from values obtained at delivery of permanent restoration i.e. loading of implants (baseline) compared to the values obtained at the follow-up visit 36 months after loading.
Positive value = bone gain, Negative values = bone loss.
Evaluated from implant loading to 36 months after implant loading.
Secondary Implant Survival Implant survival rate evaluated clinically and radiographically. Evaluated from implant installation to 36 months after implant loading.
Secondary Implant Stability Implant stability evaluated clinically/manually (recorded as stable yes/no). Evaluated 36 months after implant loading.
Secondary Condition of the Periimplant Mucosa (PPD). Condition of the periimplant mucosa measured by assessment of probing pocket depth (PPD).
Change in pocket depth expressed in millimeters at the 36 month follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).
Negative value = increased pocket depth
Evaluated from implant loading to 36 months after implant loading.
Secondary Condition of the Periimplant Mucosa (BoP). Condition of the periimplant mucosa will be measured by assessment of bleeding on probing (BoP).
Presented as % of the implants that show presence of bleeding at time of the 36 months follow-up.
Evaluated from implant loading to 36 months after implant loading.
Secondary Plaque Occurence of plaque around the study implant. Presented as proportion of implants that showed presence of plaque at the 36 months follow-up visit. Evaluated 36 months after implant loading.
Secondary Crown-to-implant Ratio Crown height measured radiographically from the implant-abutment interface to the most coronal point on the prosthesis. The crown-to-implant ratio calculated from radiographs 12 months after implant loading
See also
  Status Clinical Trial Phase
Completed NCT01473355 - Study on OsseoSpeed™ TX Narrow Implants in the Lower Jaw in a Chinese Population N/A
Active, not recruiting NCT01821417 - Performance of MicroTextured Dental Implants N/A
Completed NCT01389258 - Study on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese Population N/A
Completed NCT01389245 - Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population N/A
Enrolling by invitation NCT02054676 - Validation of the Jawbone Anatomy Classification in Endosseous Dental Implant Treatment N/A
Completed NCT01346683 - Study on OsseoSpeed™ TX Implants in a Chinese Population N/A